Pharmaceutical Executive January 26, 2022
CRISPR is a breakthrough tool in the field of genetic engineering. Scientists have known about CRISPR—clustered regularly interspaced short palindromic repeats—in DNA for decades. It wasn’t until 2011, however, that researchers affiliated with the University of California were able to harness that knowledge to successfully edit DNA using CRISPR along with its associated enzyme known as Cas9. CRISPR’s uses grow daily, with new applications being discovered at breakneck pace.
Nevertheless, it is sometimes easy to get distracted by new technology at the expense of incurring excess enterprise risk. This is especially true with CRISPR because of the ever-changing patent landscape.
The promise of CRISPR
The value of the global gene-editing market could easily double in the next few years, topping...
Today's Sponsors
Today's Sponsor